Flowserve Corporation FLS
Composite 55/100; the shares have moved about 48% annualised. Names that move more contribute more risk for the same amount invested, and our composite reflects how strong the evidence for this one is right now.
Valuation ranks 39/100 — a slight mark against it.
Balance-sheet strength ranks 66/100 — a moderate point in its favour. Growth ranks 63/100 — a moderate point in its favour. Quality ranks 59/100 — a slight point in its favour.
Valuation ranks 39/100 — a slight mark against it. Income ranks 46/100 — a slight mark against it. Momentum ranks 50/100 — a slight mark against it.
What the company does Flowserve designs, manufactures, and services industrial flow management equipment across two segments: pumps (FPD) and valves/controls (FCD). Its offerings include engineered pumps, mechanical seals, isolation and control valves, actuators, and related aftermarket services for energy, water, and process industries globally.
Key financials ROE 17.1%, ROA 7.2%, ROCE 14.1%; gross/operating/net margins 35.5%/13.4%/7.6%. Revenue fell -6.7% YoY while EPS rose 14.3%. Debt/Equity 0.83, net debt/EBITDA 1.48, interest coverage 7.79x, current ratio 2.22. Dividend yield 1.2%, payout 31.2%.
Stock health Sideravia overall score 54.6 (average quality, fairly valued), with strength 70.8 and momentum 40.5. Piotroski F-Score 7/9, Altman Z 4.05. RSI(14) 46.00; -23.86% below 52-week high.
Price vs fair value The stock trades at a PREMIUM of 16.20% versus our fair-value estimate of 58.64 and a discount of 26.68% to the 12-month target of 88.60. - Q2 aftermarket bookings rose and margins expanded, beating estimates (Zacks, 2026-07-30). - Record aftermarket bookings and raised guidance highlighted in Q2 call (GuruFocus.com, 2026-07-30). - Stock surged on Q2 sales beat (StockStory, 2026-07-29).
Looking forward Forward P/E 17.89x and PEG 0.37 suggest valuation support, but revenue growth remains negative (-6.7%) while EPS growth is positive (14.3%). Analysts see 26.68% upside to the 12-month target, implying confidence in margin and aftermarket recovery.
This is not investment advice. Sideravia provides automated, data-driven analysis for information and education only. Nothing on this page is a personal recommendation or an invitation to buy or sell any security, and it does not consider your objectives or financial situation. Assessments are generated by rules applied uniformly to every covered stock — how our scores work.
Data as of 2026-09-04, compiled from third-party sources; errors and delays are possible and figures are not warranted. Investing puts your capital at risk; past performance does not predict future results. We publish our full track record, including the calls that lost, and our conflicts of interest.